Literature DB >> 32068496

Clinical features and treatment of endolymphatic sac tumor.

Seong Hoon Bae1, Seung-Seob Kim2, Sang Hyun Kwak1, Jin Sei Jung1, Jae Young Choi1, In Seok Moon1.   

Abstract

Background: Endolymphatic sac tumor (ELST) is an extremely rare disease that does not have established clinical guidelines.Objective: To provide guidance for the diagnosis and management of ELSTs.
Methods: We retrospectively reviewed the medical records of patients who were suspected to have a lesion in the location of endolymphatic sac. Seven patients were included. Histopathologic diagnosis confirmed five ELSTs and two other diseases.
Results: All of the enrolled patients had hearing impairment. Facial palsy was found in four out of five patients with ELST, whereas none of the patients in other disease group showed facial palsy. CT and MRI findings were consistent with those in previous literatures; however, angiographic findings were not consistent with those previously reported. All patients underwent surgery. Recurrence occurred in two patients with ELST, although there was no visible remnant tumor after the operation. These patients were treated with stereotactic radiosurgery.
Conclusion: Hearing impairment and facial palsy were representative symptoms of ELST. All ELSTs showed 'salt and pepper' signal in MRI T1-weighted images, and smaller tumors could have blood supply from AICA in the radiologic study. Complete surgical resection with optional stereotactic radiosurgery should be considered in ELST.HighlightsHearing impairment and facial weakness are remarkable symptoms of ELST compared to other diseases that invade the endolymphatic sac.All ELSTs showed 'salt and pepper' signal in MRI T1-weighted images.ELST less than 3 cm in diameter could have blood supply from AICA.A complete surgical excision with optional stereotactic radiosurgery is required.

Entities:  

Keywords:  Endolymphatic Sac; facial paralysis; skull base neoplasms; temporal bone; von Hippel-Lindau disease

Mesh:

Year:  2020        PMID: 32068496     DOI: 10.1080/00016489.2020.1722855

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  The endolymphatic sac tumor: challenges in the eradication of a localized disease.

Authors:  Vittoria Sykopetrites; Gianluca Piras; Annalisa Giannuzzi; Antonio Caruso; Abdelkader Taibah; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-05       Impact factor: 2.503

2.  Stereotactic radiosurgery for the treatment of recurrent endolymphatic sac tumor: A case report and review of the literature.

Authors:  Nisha Dabhi; Stylianos Pikis; Georgios Mantziaris; Jason Sheehan
Journal:  J Radiosurg SBRT       Date:  2022

Review 3.  Symptoms and clinical features in patients affected by endolymphatic sac tumor: a systematic review and meta-analysis.

Authors:  Federico Maria Gioacchini; Shaniko Kaleci; Giuseppe Chiarella; Pasquale Viola; Davide Pisani; Alfonso Scarpa; Michele Tulli; Annalisa Pace; Giannicola Iannella; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-15       Impact factor: 3.236

4.  Endolymphatic Sac Tumor as a Ménière-Like Vertiginous Syndrome: A Case Report.

Authors:  Mario Jesus Villegas-González; Josefina Alejandra Morales-Del Angel; José Luis Treviño González; Daniel Aranda-Garcia; Germán Armando Soto-Galindo; Adriana Miroslava Pérez Peña
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.